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Purpose: It has been shown that increasing bone marrow lesions
(BMLs) in osteoarthritis (OA) are a predictor of cartilage loss. It is
not known if incident and progressive BMLs exhibit a different risk
of follow-up (FU) cartilage loss at 30 months when compared
to stable BMLs. The risk of cartilage loss in subregions of
regressing BMLs to date has not been investigated. It is further
not known if cartilage loss at FU is associated with baseline (BL)
BML volume. Hence, we examined the association of BL and
30-months FU subchondral bone marrow edema status with risk
of cartilage loss in the same subregion at FU.
Methods: The MOST study is a longitudinal observational mul-
ticenter study of OA including subjects with radiographic/clinical
OA or being at risk of developing it. All patients with available
BL and 30-months FU MRIs were included. The study popula-
tion was subdivided concerning BL and FU BML status in knee
subregions: 1. No BML at BL and at FU 2. No BML at BL and
incident BML 3. Prevalent BML at BL and decrease of BML 4.
Prevalent BML at BL and increase of BML 5. Prevalent BML at
BL and no change in BML. The latter subgroup was chosen as
the reference group for analysis.
The MRI protocol included triplanar proton-density weighted fat-
suppressed FSE sequences. MRI was performed at a 1.0 T
extremity system (ONI, OrthOne™. Subchondral BML volume
was scored semi-quantitatively from 0 to 3 in 14 subregions of
the knee. Cartilage was scored from 0 to 6 in the same subre-
gions. A logistic regression model was applied for correlations
of BML status at BL and FU with cartilage status at 30 months.
Any cartilage score change ≥0.5 was deﬁned as increase. Ad-
justment was performed for age, sex and BMI.
A subanalysis by BML volume at baseline was performed to
determine its predictive value concerning cartilage loss at 30
months.
Results: 413 knees were included and 5309 subregions ana-
lyzed. 440 BMLs were observed in a subregion at baseline. Out
of these 34.3% did not change, 49.8% showed regression and
15.9% showed progression. 281(6.0%) subregions in the absent
BML group, 101(55.4%) in the incident BML group, 62(28.3%) in
the decreasing BML group, 36(51.4%) in the progressive BML
group and 41(27.1%) in the stable BML group showed progres-
Abstract 27 – Table 1. Association of BML status at BL and 30-months follow-up with risk of cartilage loss at FU
BML status at baseline and 30-months follow-up in subregions
No BMLs at baseline Pre-existing BMLs at baseline
Cartilage status at 30-months No BML at follow-up Incident BMLs Decrease and regression of BMLs Progression of BMLs Stable BMLs
follow-up in subregions (N=4687) (N=182) (N=219) (N=70) (N=151)
Increase in cartilage score, N (%) 281 101 62 36 41
(≥0.5 worsening of cartilage grade) (6.0) (55.4) (28.3) (51.4) (27.1)
Adjusted OR of cartilage loss 0.2 3.5 1.0 2.7 1.0
[95% conﬁdence intervals] [0.1, 0.3] [2.1, 6.0] [0.6, 1.6] [1.4, 5.0] [Reference]
Abstract 27 – Table 2. Association of baseline BML volume and risk of cartilage loss at 30-months follow-up
Baseline BML volume score
Cartilage status at 30-months follow-up in subregions 0 (N=4873) 1 (N=334) 2 (N=75) 3 (N=31)
Increase in cartilage score, N(%) 382 (7.84) 100 (29.94) 25 (33.33) 14 (45.16)
Adjusted OR of cartilage loss [95% conﬁdence intervals] 1.0 [Reference] 2.9 [2.0,4.2] 4.6 [2.4, 8.8] 14.2 [6.7, 29,9]
sive cartilage loss at FU. The adjusted odds ratios (ORs) [95%
conﬁdence intervals] of progressive cartilage loss at FU for the
respective groups were 0.2 [0.1,0.3], 3.5 [2.1,6.0], 1.0 [0.6,1.6]
and 2.7 [1.4,5.0] with the group with stable BMLs as a reference
(Table 1).
382 (7.8%) subregions in the group with no BML at BL showed
cartilage loss at FU, 100 (29.9%) in the group with a BL grade 1
lesion, 25 (33.3%) with a BL grade 2 lesion and 14 (45.1%) with
a BL grade 3 lesion. The adjusted ORs were 2.9 [2.0,4.2], 4.6
[2.4, 8.8] and 14.2 [6.7, 29,9] compared with the group with no
BMLs at BL as a reference (Table 2).
Conclusions: Contrary to published data, a majority of pre-
existing BMLs showed decrease in volume at 30-months FU.
Regressing and stable BMLs exhibit the same risk of progressive
cartilage damage at FU. Progression and incidence of BMLs
is highly associated with progressive cartilage damage, while
incident BMLs exhibited the highest risk. Absence of BMLs
proved to be cartilage-protective. The risk of cartilage damage
at FU is directly associated with BML volume at BL.
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Purpose: To evaluate the potential use of 3T MRI in knee OA for
correlating semi-quantitative synovial and cartilage volumes with
severity by radiographic ﬁndings
Methods: 44 OA patients (mean age 61± 10, mean BMI
27.4±3.3, 56% female) fulﬁlling ACR criteria for knee OA were
recruited as part of an NIH OA Biomarkers Network funded
project. These patients are being followed longitudinally for pro-
gression of knee OA over a period of 2 years, and WOMAC
pain scores were calculated at the time the imaging studies
were performed. Standardized semi-ﬂexed radiographs were
scored for overall Kellgren and Lawrence (KL) grade, osteo-
phytes, joint space width (JSW) and subchondral sclerosis by
the same radiologist. Dynamic 3T MRI was performed before
and after contrast agent Gd-DTPA 0.2mg/kg (double dose). Syn-
ovial volume was evaluated with slice thickness=5mm, receiver
bandwidth=200Hz/pixel, TR/TE=12ms//3.9ms TE, Flip angle=60,
in the sagittal plane. The cartilage volume was quantitated
using T1-weighted 3D-ﬂash sequence with water excitation,
FOV=15x15 cm, Matrix=512x384, slice thickness=1.5mm, re-
ceiver bandwidth=200Hz/pixel, TR/TE=25ms/4ms, Flip angle=25,
in the sagittal plane.
